gip and glp 1 receptor agonist Tirzepatide's Unique Mechanism of Action Understand GLP-1/GIP Dual Agonist Tirzepatide

At 24 weeks, the mean relative change from baseline in liver fat was a 42.9% reduction in the 1 mg group, a 57.0% reduction at 4 mg, an 81.4% reduction at 8 mg, and an 82.4% reduction at the 12 mg dose

Basic Res Cardiol 2016

The 2.4 mg group lost the most weight, which means that among adults suffering from overweight or obesity and T2DM, SMG 2.4 mg once a week has achieved significant clinically significant weight loss (99)

Members must meet specific lifestyle modification requirements, BMI thresholds, and/or have certain co-morbid conditions that may qualify for GLP-1s

Patients currently using compounded semaglutide or tirzepatide should discuss transitioning to FDA approved formulations with their healthcare provider

There was a reduction in plasma glucose and HbA1c levels at the three highest doses of retatrutide and a dose-dependent reduction in body weight [63]